Interestingly, Yang et al. describe a series of 52 patients in which 12% tested positive for ANA antibodies (regardless of subclass) and 22% for rheumatoid factor, even without overlapping features of other autoimmune diseases, raising questions about the clinical significance of these findings in this context [9]. The gene discussed is BTG3; the disease is autoimmune disease.